New Tools for Monitoring Blood Status and Infection
By HospiMedica International staff writers Posted on 03 Nov 2014 |
Image: The DiaSpect hemoglobin analyzer (Photo courtesy of EKF Diagnostics).
Two new diagnostic tools relating to blood status and infection will be introduced at Medica, the annual showcase for biomedical products.
EKF Diagnostics (Cardiff, United Kingdom) announced that it will be highlighting its DiaSpect hemoglobin analyzer and Liquicolor Procalcitonin immunoturbidimetric assay for sepsis at this year's Medica (Düsseldorf, Germany, November 12–15, 2014).
DiaSpect is a palm-sized point of care analyzer that is fast, easy to use, and reliable in all climate conditions. The instrument utilizes reagent-free microcuvettes, which are unaffected by humidity, unlike reagent-based systems. These plexiglass microcuvettes also have a long shelf-life of 2.5 years with no need for refrigeration, as they can be stored from zero to 50 degrees Celsius. DiaSpect weighs only 185 grams and has an extremely long battery life of 40 days of continuous use, or 10,000 tests, due to its integrated rechargeable lithium-ion battery. DiaSpect is factory calibrated and requires no recalibration or maintenance, as it performs an automatic self-check between every measurement. Hemoglobin results, which are delivered in just one second, can be downloaded to a PC via USB or Bluetooth.
EKF’s novel test for early sepsis detection, the Liquicolor Procalcitonin immunoturbidimetric assay, is precise, convenient, and cost effective, as it is in a liquid-stable format that can remain stable on-board a clinical chemistry analyzer for up to four weeks and requires a minimal sample of just 20 microliters. Procalcitonin levels become elevated during systemic bacterial infection and sepsis and are an early and specific indicator of sepsis. The CE-marked Liquid Procalcitonin assay can be used on most automatic chemistry analyzers to quickly assess initial severity of sepsis.
Related Links:
EKF Diagnostics
EKF Diagnostics (Cardiff, United Kingdom) announced that it will be highlighting its DiaSpect hemoglobin analyzer and Liquicolor Procalcitonin immunoturbidimetric assay for sepsis at this year's Medica (Düsseldorf, Germany, November 12–15, 2014).
DiaSpect is a palm-sized point of care analyzer that is fast, easy to use, and reliable in all climate conditions. The instrument utilizes reagent-free microcuvettes, which are unaffected by humidity, unlike reagent-based systems. These plexiglass microcuvettes also have a long shelf-life of 2.5 years with no need for refrigeration, as they can be stored from zero to 50 degrees Celsius. DiaSpect weighs only 185 grams and has an extremely long battery life of 40 days of continuous use, or 10,000 tests, due to its integrated rechargeable lithium-ion battery. DiaSpect is factory calibrated and requires no recalibration or maintenance, as it performs an automatic self-check between every measurement. Hemoglobin results, which are delivered in just one second, can be downloaded to a PC via USB or Bluetooth.
EKF’s novel test for early sepsis detection, the Liquicolor Procalcitonin immunoturbidimetric assay, is precise, convenient, and cost effective, as it is in a liquid-stable format that can remain stable on-board a clinical chemistry analyzer for up to four weeks and requires a minimal sample of just 20 microliters. Procalcitonin levels become elevated during systemic bacterial infection and sepsis and are an early and specific indicator of sepsis. The CE-marked Liquid Procalcitonin assay can be used on most automatic chemistry analyzers to quickly assess initial severity of sepsis.
Related Links:
EKF Diagnostics
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure